SANUWAVE Health (SNVW) CEO Frank Morgan awarded 3,208 stock options

Rhea-AI Filing Summary

SANUWAVE Health, Inc. reported that Chief Executive Officer Frank C. Morgan received a grant of stock options. He was awarded options to purchase 3,208 shares of common stock at an exercise price of $17.29 per share, fully vested on the grant date. These options expire on March 31, 2031, and following this grant he holds 3,208 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider FRANK MORGAN C.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	3,208	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 3,208 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 3,208 options Exercise price: $17.29 per share Options after transaction: 3,208 options +2 more

5 metrics

Option grant size 3,208 options Stock Option (right to buy) granted to CEO

Exercise price $17.29 per share Conversion or exercise price of granted options

Options after transaction 3,208 options Total stock options held following the grant

Expiration date March 31, 2031 Option award expiration

Grant vesting status Fully vested at grant Footnote disclosure on option vesting

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, fully vested at the grant date

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

fully vested at the grant date financial

"Options were fully vested at the grant date."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANK MORGAN C.

(Last) (First) (Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$17.29	03/31/2026		A		3,208		(1)	03/31/2031	Common Stock	3,208	$0	3,208	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Morgan C. Frank	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SANUWAVE Health CEO Frank Morgan receive in this Form 4 filing for SNVW?

Frank C. Morgan received a grant of stock options to buy 3,208 shares of SANUWAVE Health common stock. The options were granted as compensation and are fully vested, meaning he can exercise them subject to the option terms.

What is the exercise price of Frank Morgan’s new SANUWAVE Health stock options?

The granted options have an exercise price of $17.29 per share. This is the price at which Frank C. Morgan can purchase SANUWAVE Health common stock under the option award, regardless of the market price at exercise time.

When do Frank Morgan’s SANUWAVE Health stock options reported on Form 4 expire?

The reported stock options expire on March 31, 2031. After this expiration date, Frank C. Morgan will no longer be able to exercise these options to purchase SANUWAVE Health common shares.

Are Frank Morgan’s SANUWAVE Health stock options from this grant vested?

Yes. A footnote states the options were fully vested at the grant date. This means Frank C. Morgan does not need to wait for a vesting schedule and may exercise the options at any time before expiration.

How many SANUWAVE Health stock options does Frank Morgan hold after this transaction?

After this grant, Frank C. Morgan holds 3,208 stock options directly. This total reflects the options reported in the Form 4 filing and shows his derivative position from this specific award.